Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00451997. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
ClinicalTrials.gov study NCT07228624. IPD Sharing: NO. Countries: 1. Publications: 0.
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03661307. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00104806. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT05457556. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00828802. IPD Sharing: Not stated. Countries: 1. Publications: 0.
iCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT03446638. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01567059. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT03469661. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions
ClinicalTrials.gov study NCT00749372. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01541280. IPD Sharing: Not stated. Countries: 1. Publications: 0.
High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-H
ClinicalTrials.gov study NCT01177371. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT00795548. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT05925504. IPD Sharing: NO. Countries: 1. Publications: 0.
TMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06598969. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT06146257. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00049582. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Creation of Bone Marrow Microenvironment for Treatment of Myelodysplastic Syndrome (MDS) in Conjunction With Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT00148980. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02250937. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00392353. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.